evidence table

N-Acetylcysteine Respiratory Infection Meta-Analysis Evidence Table

Structured evidence table for N-Acetylcysteine Respiratory Infection Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
N-Acetylcysteine Respiratory Infection Meta-AnalysisThis document consolidates existing evidence to this effect, and adds insights from practicing clinicians to guide about use of NAC in clinical practice.2Barne M (2026)N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
N-Acetylcysteine Respiratory Infection Meta-AnalysisConclusion This consensus underscores the role of NAC in chronic respiratory diseases beyond its mucolytic properties and reiterates that NAC's antioxidant, anti-inflammatory, immunomodulatory and anti-biofilm properties provide significant clinical utility.2Barne M (2026)N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
N-Acetylcysteine Respiratory Infection Meta-AnalysisWhile promising for TB and respiratory infections, further evidence is required.2Barne M (2026)N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
N-Acetylcysteine Respiratory Infection Meta-AnalysisBackground N-acetylcysteine (NAC) is a key precursor of glutathione (GSH), the lung's principal antioxidant.2Barne M (2026)N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
N-Acetylcysteine Respiratory Infection Meta-AnalysisThe virus was initially associated with Burkitt lymphoma, but since then it has also been linked to Hodgkin and non-Hodgkin lymphomas, nasopharyngeal carcinoma, gastric cancers, multiple sclerosis, systemic lupus erythematosus, and infectious mononucleosis [].4Muacevic Alexander (2026)Epstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect
N-Acetylcysteine Respiratory Infection Meta-AnalysisBased on several recent reports, NAC has shown promise in reducing inflammation associated with viral hepatitis.4Muacevic Alexander (2026)Epstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect
N-Acetylcysteine Respiratory Infection Meta-AnalysisA peripheral blood smear showed lymphocytosis with normochromic and normocytic anemia but without increased myeloblasts.4Muacevic Alexander (2026)Epstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect
N-Acetylcysteine Respiratory Infection Meta-AnalysisThe virus is highly prevalent, with up to 90% of the population worldwide infected.4Muacevic Alexander (2026)Epstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimThis document consolidates existing evidence to this effect, and adds insights from practicing clinicians to guide about use of NAC in clinical practice.
evidence level2
citationBarne M (2026)
sourceN-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimConclusion This consensus underscores the role of NAC in chronic respiratory diseases beyond its mucolytic properties and reiterates that NAC's antioxidant, anti-inflammatory, immunomodulatory and anti-biofilm properties provide significant clinical utility.
evidence level2
citationBarne M (2026)
sourceN-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimWhile promising for TB and respiratory infections, further evidence is required.
evidence level2
citationBarne M (2026)
sourceN-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimBackground N-acetylcysteine (NAC) is a key precursor of glutathione (GSH), the lung's principal antioxidant.
evidence level2
citationBarne M (2026)
sourceN-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimThe virus was initially associated with Burkitt lymphoma, but since then it has also been linked to Hodgkin and non-Hodgkin lymphomas, nasopharyngeal carcinoma, gastric cancers, multiple sclerosis, systemic lupus erythematosus, and infectious mononucleosis [].
evidence level4
citationMuacevic Alexander (2026)
sourceEpstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimBased on several recent reports, NAC has shown promise in reducing inflammation associated with viral hepatitis.
evidence level4
citationMuacevic Alexander (2026)
sourceEpstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimA peripheral blood smear showed lymphocytosis with normochromic and normocytic anemia but without increased myeloblasts.
evidence level4
citationMuacevic Alexander (2026)
sourceEpstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect
topicN-Acetylcysteine Respiratory Infection Meta-Analysis
claimThe virus is highly prevalent, with up to 90% of the population worldwide infected.
evidence level4
citationMuacevic Alexander (2026)
sourceEpstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect

Learn next

Related evidence and supplement guides

SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideNac Respiratory Infections Meta-analysis: What the Evidence SaysNac Respiratory Infections Meta-analysis has 2 source documents in the current Migaku evidence d...GuideNAC Respiratory Infection Meta-analysis: What the Evidence SaysNAC Respiratory Infection Meta-analysis has 2 source documents in the current Migaku evidence da...GuideElderberry Respiratory Symptoms Meta-analysis: What the Evidence SaysElderberry Respiratory Symptoms Meta-analysis has 2 source documents in the current Migaku evide...GuideNac Respiratory Support Meta-analysis: What the Evidence SaysNac Respiratory Support Meta-analysis has 2 source documents in the current Migaku evidence data...AnswerDoes Nac Respiratory Infections Meta-Analysis work?Nac Respiratory Infections Meta-Analysis has evidence relevant to strength of evidence and what...AnswerIs Nac Respiratory Infections Meta-Analysis safe?Nac Respiratory Infections Meta-Analysis has evidence relevant to safety, limits, and clinician-...AnswerWhat does the evidence say about Nac Respiratory Infections Meta-Analysis?Nac Respiratory Infections Meta-Analysis has evidence relevant to benefits, uncertainty, and pra...

Source documents

  1. N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR).
  2. Epstein-Barr Virus (EBV) Hepatitis Treated With N-Acetylcysteine: Placebo Versus True Effect